BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Report Library

All Reports
Datamonitor Healthcare CV&Met: Amyloidosis Market Spotlight

October 08, 2020

Amyloidosis is a rare disorder that occurs when an abnormal protein, known as amyloid, is deposited in the organs and tissues. The amyloid proteins misfold and accumulate as insoluble amyloid fibrils, generally in the extracellular space. These protein aggregates damage organs and tissues, can affect more than one organ at the same time, and affect different tissues and organs in different individuals. Amyloidosis most frequently affects the heart, kidneys, liver, nervous system, and digestive tract. The severity of amyloidosis and its symptoms depend on the tissues and organs affected.

This Datamonitor Healthcare report contains a Market Spotlight module.
Indications Covered: Amyloid light-chain (AL) Amyloidosis
Hereditary Transthyretin (hATTR) Amyloidosis With Polyneuropathy (Familial Amyloid Polyneuropathy)
Transthyretin Amyloid Cardiomyopathy (ATTR-CM, Wild Type Or Hereditary)
Back to the top Back to the top